Standard BioTools Inc. (LAB)

NASDAQ: LAB · Real-Time Price · USD

0.6419

-0.0111 (-1.70%)

Aug 28, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Medical Products	85.33M	91.01M	106.34M	-	-
Proteomics	-	-	-	52.50M	67.66M
Genomics	-	-	-	45.45M	62.92M
Total	85.33M	91.01M	106.34M	97.95M	130.58M

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Europe, Middle East and Africa (EMEA)	-	-	-	33.14M	42.72M
Americas Excl. United States	2.16M	2.00M	2.10M	2.98M	3.68M
Emea Excl. Sweden	27.39M	26.55M	29.82M	-	-
Sweden	8.60M	9.10M	6.38M	-	-
United States	28.40M	35.40M	44.10M	41.00M	60.20M
Asia-Pacific (Excl. China)	7.88M	7.95M	7.99M	10.06M	11.48M
China	10.90M	10.01M	15.95M	10.77M	12.50M
Total	85.33M	91.01M	106.34M	97.95M	130.58M